ALFA Filings
Every announcement, straight from the exchange
Every Tarsons Products earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Tarsons delivered record Q1 revenue growth of 21% YoY, yet profitability is severely squeezed by a 25-50% spike in raw material costs and heavy depreciation from new capex.
Tarsons reported 21% YoY consolidated revenue growth in Q1 FY27, reaching ₹110.2 cr, driven by domestic and export recovery despite margin pressure from raw material costs and new facility expenses.
Tarsons reported record quarterly revenue of ₹121cr (Q4 FY26). Management is focused on ramping up newly commissioned bioprocess and cell culture facilities to drive long-term operating leverage.
Tarsons reported record quarterly revenue but margins were squeezed by raw material spikes and new plant costs.
Tarsons reported FY26 consolidated revenue growth of 8% to ₹422.5 cr, while PAT declined 48% to ₹15.5 cr due to high depreciation and finance costs from new facility capitalizations.